
Marisa Novara: When it comes to affordable housing in Chicago, there is no one size fits all
There's been a lot of ink spilled recently on the high cost of delivering affordable housing. At a time when the Institute for Housing Studies at DePaul University estimates that 120,000 more Chicago households need affordable housing than what currently exists and the number of people experiencing homelessness in 2024 was threefold higher than the previous year, it's a worthy debate.
In my view, we should all be able to agree on three things.
The first: Where we can keep costs and inefficiencies down, we should.
It's up to all of us — public and private funders, developers and contractors — to stay vigilant about ways to keep costs down. Some reasons for rising costs such as high interest rates and a COVID-19-caused jump in the price of materials are out of local actors' control. Other reasons such as local government regulations — including those I imposed when I was housing commissioner — should be up for discussion. Regulations have costs, and we should be open to ongoing, vigorous debate about their tradeoffs.
One surefire way to reduce costs is to provide speed and certainty when it comes to permitting and the public approval process. We should all get behind the city's Cut the Tape initiative to streamline and expedite development processes and minimize one-off rejections by the City Council of developments that follow the city's stated principles. An example is the 2022 Connected Communities Ordinance that reinforced a citywide embrace of dense housing with reduced parking by transit. When developers offer up exactly what they were told the city wanted, let's reduce their time and uncertainty tax — and resulting costs — by getting them on the road to construction as soon as possible.
The second: We should all agree that different models have different costs.
It does not help any of us involved in or committed to the hard work of developing affordable housing to compare apples to oranges. Federally regulated Low-Income Housing Tax Credits, for instance, are built with a slew of mandated costs that do not apply to the construction of single-family homes. Similarly, 300-unit market-rate buildings have lower costs per unit than 40-unit buildings that absorb the cost of federal funds and the inefficient system that is LIHTC. All are important forms of housing, and their costs are simply not comparable.
The third: When it comes to affordable housing, there is no one size fits all.
Not all developments are trying to reach the same goals. Some developments that are pushing the envelope to reduce energy bills to their low-income tenants will cost more on the front end. We know that the savings are borne out over time by both tenants who pay less in utilities and by reduced damage to the environment. In other cases, the choice is made to instead focus on keeping the upfront costs down and buyers or tenants pay higher utility costs over time. Neither is wrong; they just have different goals.
If land or a building in a high-cost area must be purchased in order to build affordable housing, it will cost more on the front end than to do so in an area with lower property values. But as I've argued before, affordable housing belongs everywhere, not only where it's cheapest to build. Why? Lots of reasons, but I'll share one moral and one economic:
My fundamental belief is that people should have as many choices as possible about where they can live. Period. It's what sociologist Monica Bell calls 'residential freedom.'
If you think building affordable housing only where land values are low is cheaper in the long run, I've got some data for you. Chicago forgoes $8 billion in regional gross domestic product because of our high racial and economic segregation. If we were less segregated, we could benefit from $4.4 billion in additional income each year, a 30% lower homicide rate and 83,000 more bachelor's degrees, according to a 2017 study from the Metropolitan Planning Council. In the long run and in isolation, in other words, none of our options are cheap.
We live in a country in which only 1 in 4 people who qualify for affordable housing actually receive it. In Chicago, those numbers play out against a backdrop of profound racial and economic segregation. In the face of that reality, let's acknowledge that a broad tent of approaches that meet a range of goals is needed, from high-rises with 20% affordable units to backyard coach houses to publicly funded all-affordable apartments to unsubsidized rental rehabs to new construction for-sale single-family homes.
We need every creative solution in all neighborhoods for all Chicagoans. Because when our neighbors do better, we all do better.
Marisa Novara was commissioner of the Chicago Department of Housing from 2019 to 2023. She now serves as vice president of community impact at The Chicago Community Trust.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers
ARLINGTON, Va., June 13, 2025 /PRNewswire/ -- New survey insights reveal a measurable shift in how life science labs are responding to global financial uncertainty, rising operational costs, and upcoming U.S. tariff policies. Based on responses from more than 550 academic and industry researchers, the latest data from BioInformatics' Beyond the Bench series captures how lab priorities, purchasing decisions, and funding strategies have evolved from January to mid-April 2025—offering a rare pre- and post-policy view of market sentiment. While the first wave of the survey was fielded prior to the announcement of new tariff policies, the second wave offers a timely comparison as labs began adjusting to anticipated policy changes under the Trump administration and broader macroeconomic pressures, including inflation, tightened research budgets, and supply chain strain. Click here to download the Lab Budgets & Funding Survey Key Survey Findings Include: Funding confidence is declining, with only 57% of labs reporting confidence in securing 2025 funding—down from 66% in the first wave. Financial strain is hitting North American labs harder than those in Europe: 46% report new funding challenges (vs. 21% in Europe), and over half are considering personnel cuts, compared to just 28% in Europe. 42% of labs cite new concerns about securing funding through year-end, signaling heightened financial risk across the sector. Cost-saving strategies are accelerating, including resource sharing, supplier renegotiations, outsourcing, and delayed equipment purchases. These findings reflect shifting institutional priorities and underscore the growing need for timely, market-aligned planning as labs face increased constraints and financial pressure. "By fielding this survey before and after key policy announcements, we're able to offer a real-time snapshot of how labs are adjusting to economic volatility," said Richa Singh, VP, Market Insights at BioInformatics. "As tariff policies begin to reshape lab planning, companies need focused, evidence-backed insights to align their strategies. This data helps commercial teams track funding sentiment, adapt messaging, and make confident, evidence-based decisions—especially in a market where priorities can change within weeks." About Beyond the Bench Beyond the Bench is a free monthly intelligence series created by BioInformatics to help life science and diagnostics companies understand how customer sentiment and commercial priorities are shifting—particularly during times of uncertainty and industry disruption. Powered by the Science Advisory Board, BioInformatics' proprietary network of over 55,000 life science professionals, each report delivers survey-based insights on market trends, strategic shifts, and buyer behavior. The series was launched to provide a clear, unbiased view into the evolving challenges facing researchers and decision-makers—giving commercial teams actionable guidance to align strategy, messaging, and resource planning with what matters most to their customers. Access & Get Involved: Download the Lab Budgets & Funding Survey Sign up to receive monthly Beyond the Bench reports Join the Science Advisory Board — qualify to participate in surveys, earn rewards, and shape the future of scientific research. About BioInformatics BioInformatics, part of the Science and Medicine Group, is a leading market research and advisory firm serving the life science and diagnostic industries. The company delivers custom and syndicated research powered by a proprietary global panel of more than 55,000 professionals. View original content to download multimedia: SOURCE BioInformatics Inc.
Yahoo
2 hours ago
- Yahoo
Trump quips 'they didn't die of COVID' when asked if Israel killed Iranian officials
President Donald Trump joked on Friday morning about the fate of Iranian officials in the wake of Israel's recent airstrike, according to CNN's Dana Bash. After months of negotiations between the U.S. and Iran, Israel attacked Iran's nuclear and missile infrastructure early Friday, taking out at least 20 senior Iranian commanders and inflicting a significant blow to Tehran's government. Two of the most prominent officials killed in the strikes were Gen. Hossein Salami, the leader of the Islamic Revolutionary Guard Corps (IRGC) and Gen. Mohammad Bagheri, the chief of staff of the Iranian armed forces. Bash spoke on Friday about her phone call with Trump, where she asked him about Secretary of State Marco Rubio's initial statement about Israel's strikes, which did not explicitly say that the U.S. supported them. Trump Believes Israel's Strike On Iran Could Improve Chances For Nuclear Deal: Report "We, of course, support Israel, obviously, and supported it like nobody has ever supported it," Trump said, according to Bash. "It was a very successful attack. Iran should have listened to me when I said - you know, I gave them, I don't know if you know, but I gave them a 60-day warning. And today is day 61." "They should now come to the table to make a deal before it's too late. It will be too late for them. You know, the people I was dealing with are dead," he added, though he wouldn't give specific names, only that the "hardliners" were dead. Read On The Fox News App "This is as a result of the attack last night?" Bash asked him. "Yeah. They didn't die of the flu. They didn't die of COVID," Bash described him saying "quite sarcastically." Click Here For More Coverage Of Media And Culture Trump also told Fox News' Bret Baier on Friday that "The Iranians were hit 10 times worse than they thought they would be." "They weren't ready to negotiate. I think they may be now. We'll see," Trump said regarding the future of Iran's nuclear program. Senior U.S. officials told Fox News that a long list of nuclear scientists and military leaders were targeted by Israel's surprise airstrikes Friday. The officials added that 90% of Iran's top nuclear scientists, as well as other senior military officers and other Iranian leaders, may have been targeted in the article source: Trump quips 'they didn't die of COVID' when asked if Israel killed Iranian officials
Yahoo
2 hours ago
- Yahoo
Previewing Q2 Earnings Expectations
The expectation is for Q2 earnings to increase by +5.1% from the same period last year on +3.8% higher revenues. This will be a material deceleration from the +11.9% earnings growth in Q1 on +3.6% revenue growth. In the unlikely event that actual Q2 earnings growth for the S&P 500 index turns out to be +5.1%, as currently expected, this will be the lowest earnings growth pace for the index since the +4.3% growth rate in 2023 Q3. We have been regularly flagging in recent weeks that 2025 Q2 earnings estimates have been steadily decreasing, as shown in the chart below. Image Source: Zacks Investment Research The magnitude of cuts to 2025 Q2 estimates since the start of the period is larger and more widespread compared to what we have become accustomed to seeing in the post-COVID period. Since the start of April, Q2 estimates have declined for 14 of the 16 Zacks sectors (Aerospace and Utilities are the only sectors whose estimates have increased), with the largest cuts to Conglomerates, Autos, Transportation, Energy, Basic Materials, and Construction sectors. Estimates for the Tech and Finance sectors, the largest earnings contributors to the S&P 500 index, accounting for more than 50% of all index earnings, have also been cut since the quarter got underway. But as we have been pointing out in recent weeks, the revisions trend for the Tech sector has notably stabilized in recent weeks, which you can see in the chart below. Image Source: Zacks Investment Research We see this same trend at play in annual estimates as well. The chart below shows the Tech sector's evolving earnings expectations for full-year 2025 Image Source: Zacks Investment Research A likely explanation for this stabilization in the revisions trend is the easing of tariff uncertainty after the more punitive version of the tariff regime was delayed. Analysts started revising their estimates lower in the immediate aftermath of the early April tariff announcements, but appear to have since concluded that those punitive tariff levels are unlikely to get levied, helping stabilize the revisions trend. The chart below shows current Q2 earnings and revenue growth expectations in the context of the preceding four quarters and the coming three quarters. Image Source: Zacks Investment Research The chart below shows the overall earnings picture on a calendar-year basis. Image Source: Zacks Investment Research In terms of S&P 500 index 'EPS', these growth rates approximate to $254.04 for 2025 and $287 for 2026. The chart below shows how these calendar year 2025 earnings growth expectations have evolved since the start of Q2. As you can see below, estimates fell sharply at the beginning of the quarter, which coincided with the tariff announcements, but have notably stabilized over the last four to six weeks. Image Source: Zacks Investment Research Key Earnings Reports This week The Q2 earnings season will really get going when the big banks come out with their June-quarter results in about a month. But we will have officially counted almost two dozen quarterly reports from S&P 500 members by then. All of those reports will be from companies with fiscal quarters ending in May, which we and other research organizations count as part of the June-quarter tally. We have seen such fiscal May-quarter results from four S&P 500 members, including last Wednesday's strong release from Oracle ORCL. We have another six S&P 500 members scheduled to report results this week, including Accenture ACN, Lennar LEN, and others. Oracle shares were up significantly following the beat-and-raise quarterly release, which came after two consecutive quarterly reports that market participants had found disappointing. Oracle's cloud growth appears to have finally arrived, with fiscal 2026 cloud revenues expected to grow by +40%, up from the fiscal 2025 growth rate of +24% (Oracle's fiscal year ends in May). As noted earlier, the stock has spiked on the earnings release and is now up +29.3% this year, handily outperforming the S&P 500 index (up +2.1%) and the Zacks Tech sector (up +2.5%). Shares of IT consulting firm Accenture have been under pressure lately, reflecting a challenging operating environment for its end-markets. The stock is down -11.4% this year, which compares to a +2.1% gain for the S&P 500 index and a +2.5% gain for the Zacks Tech sector. The issues in the Accenture story, in a generalized qualitative sense, pertain to the negative effects on corporate IT budgets of the ongoing tariff uncertainty and the deflationary effects of AI-driven operating efficiencies. One could argue that Accenture's scale lends its results considerable stability, particularly in comparison to other peers like India-based Infosys, TCS, and Wipro. But these macro headwinds nevertheless limit the stock's near-term upside potential. The company is scheduled to report results on June 20th, with estimates essentially unchanged over the last two months. Lennar, the homebuilder, is scheduled to report results after the market's close on Monday, June 16th. The homebuilder is expected to bring in $1.97 per share in earnings on $8.24 billion in revenues, representing year-over-year changes of -41.7% and -5.97%, respectively. This is a challenging environment for Lennar and other homebuilders, with demand hindered by affordability concerns and elevated mortgage rates. The stock was down after each of the last five quarterly releases and has lost roughly a fifth of its value this year (down -20.3%), which compares to the Zacks Construction sector's -1.9% decline and the S&P 500 index's +2.2% gain. Q2 Earnings Season Scorecard As noted earlier, we have already seen fiscal May-quarter results from four S&P 500 members, which we include in our Q2 tally. Total earnings for these four index members that have reported results are up +4.7% from the same period last year on +8.6% revenue gains, with 75% of the companies beating EPS estimates and all beating revenue estimates. The comparison charts below put the Q2 earnings and revenue growth rates for these index members in a historical context. Image Source: Zacks Investment Research The comparison charts below put the Q2 EPS and revenue beats percentages in a historical context. Image Source: Zacks Investment Research We are not drawing any conclusions from these results, given the small sample size at this stage. But we nevertheless wanted to put these early results in a historical context. For a detailed view of the evolving earnings picture, please check out our weekly Earnings Trends report here >>>> Earnings Estimates Stabilize: A Closer Look Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Accenture PLC (ACN) : Free Stock Analysis Report Oracle Corporation (ORCL) : Free Stock Analysis Report Lennar Corporation (LEN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio